Predictive oncology announces collaboration with integra therapeutics to advance gene therapy

Eagan, minn., march 30, 2023 (globe newswire) -- predictive oncology (nasdaq: poai), a science-driven company on the leading edge of oncology drug discovery and development, today announces it is partnering with integra therapeutics, a company focused on engineering the next generation of gene writing tools to cure diseases.
POAI Ratings Summary
POAI Quant Ranking